US drug maker Eli Lilly is cutting its investment in a German factory by half. This decision follows new healthcare cost-cutting laws in Germany. The company CEO called the reforms a bad signal for the industry. This move impacts Germany’s industrial plans. The factory will now operate at reduced capacity with fewer jobs. Other companies are also reconsidering local investments.
Post Content
Samsung Electronics is on the cusp of exceeding 200 trillion won in cash assets, driven…
After years of persistent complaints regarding dust and noise produced by the nearby mining operation,…
In the 1830s, Dr John Cook Bennett suggested that tomatoes had medicinal properties for treating…
BJP president Nitin Nabin highlighted L K Advani's legacy during a special event for his…
In Rajasthan, a troubling disparity has emerged regarding the electoral rolls for local body elections,…